Use of Favipiravir to Treat Lassa Virus Infection in Macaques (Q58777764)

13

David Safronetz

0 references

Cynthia Martellaro

5

Cynthia Martellaro

0 references

Friederike Feldmann

6

Friederike Feldmann

0 references

Greg Saturday

7

Greg Saturday

0 references

Kyle Rosenke

1

Kyle Rosenke

0 references

Jonna B Westover

3

Jonna B Westover

0 references

Yousuke Furuta

10

Yousuke Furuta

0 references

Takashi Komeno

11

Takashi Komeno

0 references

Brian B Gowen

12

Brian B Gowen

0 references

author name string

Patrick William Hanley

4

0 references

Jamie Lovaglio

8

0 references

Dana P Scott

Emerging Infectious Diseases

9

0 references

language of work or name

English

0 references

publication date

September 2018

0 references

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

0 references

volume

24

0 references

issue

9

0 references

page(s)

1696-1699

0 references

cites work

Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6106425

Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6106425

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6106425

Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6106425

Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6106425

The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6106425

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6106425

Pathogenesis of Lassa fever

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6106425

Lassa fever in West Africa: evidence for an expanded region of endemicity

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6106425

Pathogenesis of Lassa fever in cynomolgus macaques

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6106425

Ribavirin for Lassa fever postexposure prophylaxis

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6106425

Review of the Literature and Proposed Guidelines for the Use of Oral Ribavirin as Postexposure Prophylaxis for Lassa Fever

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6106425

Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6106425

Lassa fever. Effective therapy with ribavirin

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6106425